Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenoma
Research reports from University of Duisburg-Essen provide new insights into adenoma
July 1st, 2008
" Somatostatin mediates its action through five receptor subtypes (sst1-5) that are widely distributed in various endocrine tissues and tumours. Because of the inhibitory effects of somatostatin, long-acting analogues have been synthesized," scientists writing in the journal Clinical Endocrinology report. "In contrast to their well-established use in neuroendocrine and pituitary tumours, little is known about their potential use in adrenal tumours. We examined somatostatin receptor protein expression in adrenal tumours of various aetiologies. Immunostaining was performed with specific polyclonal antibodies for sst1-5. Seven benign and eight malignant...
Source: Cancer Weekly (2008-07-01)
|
